Kathleen Peterson works with life sciences companies to help them understand and comply with the myriad of health regulatory obligations applicable to commercial drug and biologic products.

Whether it’s a small biologic manufacturer preparing to launch your first product, or an established pharmaceutical manufacturer with a portfolio of marketed drugs, Kathleen assists in analyzing, understanding, and implementing complex government price-reporting requirements, such as those under the Medicaid Drug Rebate Program, the 340B Drug Discount Program, and Medicare Part B. Kathleen also works with companies in reviewing various legal issues in connection with commercial contracting and discounting strategies, as well as patient assistance and free goods programs.

Prior to joining Hogan Lovells, Kathleen worked at another leading law firm. She has also worked as in-house counsel at a pharmaceutical manufacturer, allowing her to appreciate the view from "both sides of the table."

Kathleen strives to deliver practical advice to help her clients achieve their business goals while remaining compliant. With a primary practice focus on government pricing matters, but significant experience in fraud and abuse, managed care contracting, Medicare Part D, and FDCA regulatory matters, her legal advice is informed by over 15 years of cross-industry experience. Kathleen is a frequent public speaker and author of the chapter on the Medicare Part D drug benefit in the American Health Lawyers Association's "Medicare Law" (3rd ed. 2012).